Showing results (101-110 of 322) with videos related to
Sort By:
Pageof 33
Journal of Chemical Information and Modeling|September 15, 2016
Interacting with GPCRs: Using Interaction Fingerprints for Virtual ScreeningEelke B Lenselink, Willem Jespers, Herman W T van Vlijmen, et al.Journal of Medicinal Chemistry|July 24, 2008
False positives in a reporter gene assay: identification and synthesis of substituted N-pyridin-2-ylbenzamides as competitive inhibitors of firefly luciferaseLaura H Heitman, Jacobus P D van Veldhoven, Annelien M Zweemer, et al.European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|November 1, 2003
Blood-brain barrier transport of synthetic adenosine A1 receptor agonists in vitro: structure transport relationshipsMarloes P Schaddelee, Heleen L Voorwinden, Dorien Groenendaal, et al.Biochemical Pharmacology|February 5, 2003
Differential allosteric modulation by amiloride analogues of agonist and antagonist binding at A(1) and A(3) adenosine receptorsZhan-Guo Gao, Neli Melman, Andreas Erdmann, et al.European Journal of Pharmacology|June 24, 2003
Partial adenosine A(1) receptor agonists inhibit sarin-induced epileptiform activity in the hippocampal slicePatrick K Harrison, Tjerk J H Bueters, Adriaan P Ijzerman, et al.Journal of Medicinal Chemistry|March 12, 2013
Strategies to reduce HERG K+ channel blockade. Exploring heteroaromaticity and rigidity in novel pyridine analogues of dofetilideJoão F S Carvalho, Julien Louvel, Maarten L J Doornbos, et al.Journal of Cheminformatics|September 25, 2013
Benchmarking of protein descriptor sets in proteochemometric modeling (part 1): comparative study of 13 amino acid descriptor setsGerard Jp van Westen, Remco F Swier, Jörg K Wegner, et al.Biochemical Pharmacology|July 13, 2020
Design and pharmacological profile of a novel covalent partial agonist for the adenosine A1 receptorXue Yang, Majlen A Dilweg, Dion Osemwengie, et al.European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|January 1, 2005
Brain penetration of synthetic adenosine A1 receptor agonists in situ: role of the rENT1 nucleoside transporter and binding to blood constituentsMarloes P Schaddelee, Kevin D Read, Cindy G J Cleypool, et al.British Journal of Pharmacology|September 24, 2015
Characterization of 12 GnRH peptide agonists - a kinetic perspectiveIndira Nederpelt, Victoria Georgi, Felix Schiele, et al.Pageof 33